Patent details

Basic Information

Publication number:

EP3045475

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161569512

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BCR-COMPLEX-SPECIFIC ANTIBODIES AND METHODS OF USING SAME

French Title of Invention:

ANTICORPS SPECIFIQUES DU COMPLEXE BCR ET PROCEDES POUR LES UTILISER

German Title of Invention:

BCR-KOMPLEX-SPEZIFISCHE ANTIKORPER UND VERFAHREN ZU IHRER VERWENDUNG

SPC Number:

Dates

Filing date:

25/03/2009

Grant date:

04/10/2017

EP Publication Date:

20/07/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/10/2017

EP B1 Publication Date:

04/10/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/03/2018

Expiration date:

25/03/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/10/2017

 

 

Name:

MacroGenics, Inc.

Address:

9704 Medical Center Drive, Rockville, MD 20850, United States (US)

Inventor

1

Name:

Huang, Ling

Address:

United States (US)

2

Name:

Johnson, Leslie S.

Address:

United States (US)

Priority

Priority Number:

41659 P

Priority Date:

02/04/2008

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; C12P 21/08;

Publication

European Patent Bulletin

Issue number:

201740

Publication date:

04/10/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1